We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APD icon
51
Air Products & Chemicals
APD
$65.1B
$65.6M 0.45%
256,297
+7,305
+3% +$2.02M
MA icon
52
Mastercard
MA
$488B
$65.5M 0.45%
188,282
+41,835
+29% +$15.2M
EMR icon
53
Emerson Electric
EMR
$83.2B
$62.6M 0.43%
664,806
+1,713
+0.3% +$171K
AZN icon
54
AstraZeneca
AZN
$262B
$61.8M 0.42%
514,217
+385,524
+300% +$44.9M
EL icon
55
Estee Lauder
EL
$29.9B
$60.4M 0.41%
201,387
+40,845
+25% +$13.3M
MCD icon
56
McDonald's
MCD
$192B
$60.3M 0.41%
249,980
+8,051
+3% +$1.92M
AWK icon
57
American Water Works
AWK
$26.3B
$60.1M 0.41%
355,679
-34,290
-9% -$5.99M
EXEL icon
58
Exelixis
EXEL
$14.1B
$57.9M 0.39%
2,738,803
-29,144
-1% -$541K
TXN icon
59
Texas Instruments
TXN
$252B
$57M 0.39%
296,607
+44,688
+18% +$8.52M
SYK icon
60
Stryker
SYK
$129B
$54.1M 0.37%
205,325
+41,422
+25% +$11.1M
ANSS
61
DELISTED
Ansys
ANSS
$53.5M 0.36%
157,262
+2,691
+2% +$972K
VZ icon
62
Verizon
VZ
$198B
$53.2M 0.36%
984,776
-17,801
-2% -$985K
LOW icon
63
Lowe's Companies
LOW
$119B
$52.7M 0.36%
259,981
-15,396
-6% -$3.07M
PTC icon
64
PTC
PTC
$14.5B
$52.6M 0.36%
439,444
+110,334
+34% +$14.7M
BKNG icon
65
Booking.com
BKNG
$145B
$51.2M 0.35%
539,650
-24,575
-4% -$2.2M
INCY icon
66
Incyte
INCY
$23.9B
$51.1M 0.35%
742,740
+70,846
+11% +$5.38M
KO icon
67
Coca-Cola
KO
$362B
$50.8M 0.35%
967,328
+45,747
+5% +$2.55M
IQV icon
68
IQVIA
IQV
$35.3B
$50.6M 0.34%
211,223
+9,543
+5% +$2.41M
OC icon
69
Owens Corning
OC
$11.5B
$50.6M 0.34%
591,731
+104,758
+22% +$9.85M
SCHW
70
Charles Schwab
SCHW
$181B
$49.5M 0.34%
679,594
+160,911
+31% +$11.5M
ONC
71
BeOne Medicines Ltd
ONC
$34B
$49.5M 0.34%
136,281
+5,686
+4% +$1.86M
JPM icon
72
JPMorgan Chase
JPM
$944B
$48.8M 0.33%
298,234
-7,033
-2% -$1.1M
ATVI
73
DELISTED
Activision Blizzard
ATVI
$48.5M 0.33%
627,317
+313,888
+100% +$26.2M
CMCSA icon
74
Comcast
CMCSA
$82.2B
$47.8M 0.33%
855,429
+148,661
+21% +$8.67M
TJX icon
75
TJX Companies
TJX
$173B
$47.3M 0.32%
717,190
+346,116
+93% +$24.2M

Similar funds

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.